Search research articles
Contact Us
Filters
Showing results (431-440 of 443) with videos related to
Page
of 45
Sort By:
Journal of the National Cancer Institute. Monographs
|
June 12, 2015
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)
Vito Amoroso, Daniele Generali, Thomas Buchholz, et al.
The Journal of Clinical Investigation
|
July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter
Adèle Hannigan, Paul Smith, Gabriela Kalna, et al.
Cell Metabolism
|
September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R Lord, Wei-Chen Cheng, Dan Liu, et al.
JCI Insight
|
May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
Mara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer
Michael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Cancer Cell
|
January 14, 2015
Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress
Zachary T Schug, Barrie Peck, Dylan T Jones, et al.
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)
Alfredo Berruti, Daniele Generali, Manfred Kaufmann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Erik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Journal of Extracellular Vesicles
|
February 7, 2024
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Joshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Nature Reviews. Clinical Oncology
|
October 12, 2016
Imaging biomarker roadmap for cancer studies
James P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 443) with videos related to
Sort By:
Page
of 45
Journal of the National Cancer Institute. Monographs
|
June 12, 2015
International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)
Vito Amoroso, Daniele Generali, Thomas Buchholz, et al.
The Journal of Clinical Investigation
|
July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter
Adèle Hannigan, Paul Smith, Gabriela Kalna, et al.
Cell Metabolism
|
September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R Lord, Wei-Chen Cheng, Dan Liu, et al.
JCI Insight
|
May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
Mara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer
Michael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Cancer Cell
|
January 14, 2015
Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress
Zachary T Schug, Barrie Peck, Dylan T Jones, et al.
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)
Alfredo Berruti, Daniele Generali, Manfred Kaufmann, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Erik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Journal of Extracellular Vesicles
|
February 7, 2024
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Joshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Nature Reviews. Clinical Oncology
|
October 12, 2016
Imaging biomarker roadmap for cancer studies
James P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Page
of 45